Is there a role for longer courses of antibiotic therapy for infections caused by Actinomyces neuii, similar to courses used for infections caused by other species of Actinomyces, now that it has been reclassified under the genus Winkia?   

For example, for the clinical syndrome of vertebral osteomyelitis without epidural abscess secondary to Winkia neuii, would you treat with the usual 6 weeks of antibiotic therapy for osteomyelitis, or treat for longer given its prior nomenclature as part of the genus Actinomyces?